FDA approved
A branded option approved for chronic weight management.
Online access to provider guided wellness programs
REJUVONIXChecking session…
FDA-approved branded medication
Zepbound® Injection
with Tirzepatide
- FDA-approved branded medication
- Targets GIP and GLP-1 receptors
- Once-weekly injection
01
Once weeklyInjection•Once weekly•Provider reviewed•Connected care
Meet Zepbound® Injection
Prescription care designed to fit real life.
Zepbound® is a once-weekly prescription GIP and GLP-1 receptor agonist for chronic weight management in eligible adults, used with reduced-calorie nutrition and increased physical activity.
About the treatment
✓ Contains tirzepatide, a GIP and GLP-1 receptor agonist.
✓ It can affect appetite, food intake and gastric emptying.
✓ A provider determines eligibility, dose and follow-up needs.
How to take it
✓ Inject once weekly as prescribed
✓ Use under the skin in an approved injection area
✓ Rotate injection areas and follow device instructions
Treatment at a glance
Dual-receptor treatment in a weekly injection.
Dual action
Targets both GIP and GLP-1 receptors.
Provider managed
Your provider reviews response before any dose change.
Complete support
More than medication.
Keep assessment details, provider messages, fulfillment updates, progress check-ins and lifestyle guidance together when the clinical integration is active.
Explore the planned program✓Personalized treatment plan
✓Provider messaging
✓Order and fulfillment updates
✓Progress check-ins
✓Nutrition and movement guidance
Compare options
Which treatment may be right for you?
A licensed provider reviews your intake and determines what is medically appropriate.
Compounded medication01
Compounded prescription option
GLP-1 Injections
Injection · Usually once weeklyView treatment →Compounded medication02
Compounded prescription option
GLP-1 Tablets
Dissolvable tablet · Usually once dailyView treatment →FDA-approved branded medication03
Semaglutide
Wegovy® Pill
Oral tablet · Once dailyView treatment →Important safety information
Know the risks before treatment.
Zepbound® has a boxed warning about the risk of thyroid C-cell tumors. Do not use Zepbound® if you or a family member have had medullary thyroid carcinoma or if you have Multiple Endocrine Neoplasia syndrome type 2. Review the complete prescribing information with your provider.
Tell your provider about all medical conditions, allergies, pregnancy plans, and every prescription, over-the-counter medicine and supplement you use. Seek urgent care for a medical emergency.
Official FDA Prescribing Information (PDF) ↗
Read the safety overview →Frequently asked questions
Common questions about Zepbound® Injection.
Is Zepbound® Injection guaranteed after the assessment?+
No. A licensed provider decides whether treatment is appropriate.
How is my dose selected?+
Your provider selects the prescription and adjusts it only when clinically appropriate.
Where does medication come from?+
If prescribed, an independent licensed pharmacy dispenses and ships the medication.
Can I ask questions after starting?+
Yes. Use the platform for provider messages and required follow-up.
Get started